Your browser version may not work well with NCBI's Web applications. More information here...
1: Pharmacotherapy. 2003 Mar;23(3):339-48.Links

Pleconaril, a novel antipicornaviral agent.

Florea NR, Maglio D, Nicolau DP.

Department of Pharmacy Research, Hartford Hospital, Hartford, Connecticut 06102, USA.

Despite the availability of therapy for selected symptoms, no specific antiviral agents are available to treat or prevent infections due to the viruses of the Picornaviridae family--rhinoviruses and enteroviruses. Characterization of the three-dimensional structure of picornaviruses in the 1980s allowed development of compounds targeted at the virus itself. Pleconaril is a novel, orally available, systemically acting molecule whose pharmacokinetics are characterized by a two-compartment open model with first-order absorption and with a safety profile similar to that of placebo. It shows promising results in treatment of picornaviral respiratory tract infections, meningitis, and other life-threatening infections.

PMID: 12627933 [PubMed - indexed for MEDLINE]